Literature DB >> 8262387

Cloning and expression of a cDNA covering the complete coding region of the P32 subunit of human pre-mRNA splicing factor SF2.

B Honoré1, P Madsen, H H Rasmussen, J Vandekerckhove, J E Celis, H Leffers.   

Abstract

We have cloned and expressed a cDNA encoding the 32-kDa subunit (P32) of the human pre-mRNA splicing factor, SF2. This cDNA extends beyond the 5'-end of a previously reported cDNA [Krainer et al., Cell 66 (1991) 383-394]. Importantly, our fragment includes an ATG start codon which was absent from the previously reported cDNA, where it was suggested that translation might initiate at a CTG codon instead of at an ATG codon. Using the vaccinia virus (Vv) expression system, we demonstrate that translation starts at the conventional ATG start codon and not at the CTG codon. The protein is synthesized as a pro-protein of 282 amino acids (aa) that is post-translationally processed by removal of the initial 73 aa to a mature protein of 209 aa.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8262387     DOI: 10.1016/0378-1119(93)90108-f

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  18 in total

1.  By-passing selection: direct screening for antibody-antigen interactions using protein arrays.

Authors:  L J Holt; K Büssow; G Walter; I M Tomlinson
Journal:  Nucleic Acids Res       Date:  2000-08-01       Impact factor: 16.971

2.  The Herpesvirus Saimiri open reading frame 73 gene product interacts with the cellular protein p32.

Authors:  Kersten T Hall; Mathew S Giles; Michael A Calderwood; Delyth J Goodwin; David A Matthews; Adrian Whitehouse
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Rubella virus capsid associates with host cell protein p32 and localizes to mitochondria.

Authors:  M D Beatch; T C Hobman
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

Review 4.  Interpreting cDNA sequences: some insights from studies on translation.

Authors:  M Kozak
Journal:  Mamm Genome       Date:  1996-08       Impact factor: 2.957

5.  Overexpression of hyaluronan-binding protein 1 (HABP1/p32/gC1qR) in HepG2 cells leads to increased hyaluronan synthesis and cell proliferation by up-regulation of cyclin D1 in AKT-dependent pathway.

Authors:  Rachna Kaul; Paramita Saha; Mallampati Saradhi; Ramachandra L A Prasad; Soumya Chatterjee; Ilora Ghosh; Rakesh K Tyagi; Kasturi Datta
Journal:  J Biol Chem       Date:  2012-03-26       Impact factor: 5.157

6.  Inhibition of interferon-mediated antiviral activity by murine gammaherpesvirus 68 latency-associated M2 protein.

Authors:  Xiaozhen Liang; Young C Shin; Robert E Means; Jae U Jung
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Staphylococcus aureus protein A recognizes platelet gC1qR/p33: a novel mechanism for staphylococcal interactions with platelets.

Authors:  T Nguyen; B Ghebrehiwet; E I Peerschke
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

8.  Differences in virus-induced cell morphology and in virus maturation between MVA and other strains (WR, Ankara, and NYCBH) of vaccinia virus in infected human cells.

Authors:  Juan Carlos Gallego-Gómez; Cristina Risco; Dolores Rodríguez; Pilar Cabezas; Susana Guerra; José L Carrascosa; Mariano Esteban
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Open reading frame P--a herpes simplex virus gene repressed during productive infection encodes a protein that binds a splicing factor and reduces synthesis of viral proteins made from spliced mRNA.

Authors:  R Bruni; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

10.  CDK13, a new potential human immunodeficiency virus type 1 inhibitory factor regulating viral mRNA splicing.

Authors:  Reem Berro; Caitlin Pedati; Kylene Kehn-Hall; Weilin Wu; Zachary Klase; Yasmine Even; Anne-Marie Genevière; Tatiana Ammosova; Sergei Nekhai; Fatah Kashanchi
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.